Benitec Biopharma Inc.
12.45USD
-0.2750 (-2.16%)
Fetching financial statements from SEC filings…
| In $M except per-share | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24* |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | — | 0 | 0 | 0 | 0 |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Operating Income | -14 | -13 | -10 | -10 | -15 | -11 | -6 | -6 |
| Net Income | -12 | -12 | -9 | -9 | -15 | -10 | -5 | -5 |
| EPS (Diluted) | $-0.24 | $-0.26 | $-0.22 | $-0.21 | $-0.38 | $-0.26 | $-0.18 | $-0.11 |
* Derived period (computed from FY minus reported quarters). Source: SEC filings (EDGAR)